Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab and Polypectomy in Chronic Rhinosinusitis
NCT05923047Phase 4Unknown
- Sponsor
- IDIVAL
- Start
- Sep 2023
- Primary completion
- Sep 2024
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of mepolizumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by IDIVAL. Status: unknown.
02
Drugs
mepolizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT05923047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05923047.